Molina Healthcare Reports Steep Q1 Earnings Decline Amid Revenue Drop and Impairment Charge
Summary
Molina Healthcare reported a significant 95% drop in GAAP diluted EPS and a 4% decline in premium revenue for Q1 2026, including a $93 million impairment, while reaffirming its full-year guidance.
Key Events
-
Significant Earnings Decline
GAAP diluted EPS fell 95% to $0.27, and adjusted diluted EPS fell 61% to $2.35 year-over-year for the first quarter of 2026.
-
Revenue Decrease
Premium revenue decreased 4% year-over-year to $10.2 billion, primarily due to lower Medicaid and Marketplace membership.
-
Intangible Asset Impairment
The company recorded a $93 million impairment charge related to its planned exit from the Medicare Advantage-Part D product for 2027.
-
Reaffirmed Full-Year Guidance
Molina Healthcare reaffirmed its full-year 2026 premium revenue guidance of approximately $42 billion and adjusted earnings guidance of at least $5.00 per diluted share.
Analysis
The first quarter results for Molina Healthcare show a substantial deterioration in financial performance, with GAAP earnings per share plummeting 95% and adjusted earnings per share down 61% year-over-year. This decline is primarily attributed to a 4% decrease in premium revenue, driven by lower Medicaid and Marketplace membership, and a significant $93 million impairment charge related to exiting a Medicare Advantage-Part D product. The higher Medical Care Ratio also indicates increased medical costs. While the company reaffirmed its full-year 2026 guidance, the severe underperformance in the first quarter, coupled with ongoing membership challenges, raises concerns about the achievability of that guidance and the company's operational efficiency. Investors should monitor future reports for signs of stabilization in membership and medical cost trends.
At the time of this filing, MOH was trading at $156.15 on NYSE in the Finance sector, with a market capitalization of approximately $8B. The 52-week trading range was $121.06 to $333.22. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.